Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Bronchud

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Haemopoietic growth factors: uses and misusesM H Bronchud
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
The importance of dose: lymphomas as a model of chemosensitive malignanciesM H Bronchud
Medical Hypotheses|October 12, 2002
Is cancer really a 'local' cellular clonal disease?M H Bronchud
Oncology|March 1, 1994
Recombinant human granulocyte colony-stimulating factor in the management of cancer patients: five years onM H Bronchud
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
What can we expect from myeloid growth factors?M H Bronchud
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Haemopoietic growth factors: unravelling the secrets of blood formationM H Bronchud
Blood Reviews|March 1, 1989
Clinical use of haematopoietic growth factorsM H Bronchud, T M Dexter
British Medical Bulletin|April 1, 1989
Clinical use of growth factorsM H Bronchud, T M Dexter
Blood|September 15, 1996
Filgrastim (r-metHuG-CSF): the first 10 yearsK Welte, J Gabrilove, M H Bronchud, et al.
British Journal of Cancer|July 1, 1989
The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancerM H Bronchud, A Howell, D Crowther, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Haemopoietic growth factors: uses and misusesM H Bronchud
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
The importance of dose: lymphomas as a model of chemosensitive malignanciesM H Bronchud
Medical Hypotheses|October 12, 2002
Is cancer really a 'local' cellular clonal disease?M H Bronchud
Oncology|March 1, 1994
Recombinant human granulocyte colony-stimulating factor in the management of cancer patients: five years onM H Bronchud
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
What can we expect from myeloid growth factors?M H Bronchud
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Haemopoietic growth factors: unravelling the secrets of blood formationM H Bronchud
Blood Reviews|March 1, 1989
Clinical use of haematopoietic growth factorsM H Bronchud, T M Dexter
British Medical Bulletin|April 1, 1989
Clinical use of growth factorsM H Bronchud, T M Dexter
Blood|September 15, 1996
Filgrastim (r-metHuG-CSF): the first 10 yearsK Welte, J Gabrilove, M H Bronchud, et al.
British Journal of Cancer|July 1, 1989
The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancerM H Bronchud, A Howell, D Crowther, et al.
Pageof 2